FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16578111000001105: Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57911601000001118 Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57911701000001111 Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Is a Generic Femoston 2/10mg tablets true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Is a Femoston 2/10 true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Synthetic progestogen false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) 84 tablet Has AMP True Femoston 2/10mg tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start